The young Italian researcher Fabrizio Chiodo, a collaborator at the Finlay Institute of Vaccines, in Havana, was in charge of selecting the participants in the joint trial with the Amedeo di Savoia Hospital, in Turin, whose names he did not know, because, due to ethics, “They were just numbers,” he explained to Prensa Latina.
Age, weight, illnesses and allergies, among other parameters of a homogeneous and healthy population group, were taken into account among the applicants to enroll in the study, whose objective is to verify the efficacy of the Soberana Plus preparation, prepared by the Finaly Institute, as reinforcement in people immunized with other injectables against Covid-19, authorized in Italy.
Podcast Italian volunteers bet on Sovereign Plus
At the “La Pradera” International Health Center, the volunteers received the dose of Soberana Plus, after providing blood samples to be analyzed by Cuban institutions, in a procedure similar to the one carried out, 28 days later, at the Microbiology and Virology Laboratory. of the Amédeo di Savoia.
A big yes to Cuba’s vaccine (+Video + Audio)
One of the participants in the study was Matteo Saccani, an economist, who, in dialogue with Prensa Latina, stated two main reasons for joining the group.
Above all, he said, it was an honor for me, as for all of us, to put our body at the service of Cuban medical science and give our small contribution, our small support to the development of the vaccine exchange between Cuba and Europe.”
Cuban medical brigades in Italy, bridges of scientific collaboration (+Photos +Video +Audio)
The other reason, he added, “was to take care of my body, it was spectacular for us to have the possibility of getting a vaccine developed by a public health system like the Cuban one.”
A vaccine without any economic interest behind it, which is why it offers much more confidence for us and so putting it on us was an honor, he specified.
In addition, he stressed that the “clinical trial went extremely well” and was an opportunity to verify, once again, “the seriousness with which the scientists work” on the island.
Indira Estrada, a Cuban engineer residing in Italy, pointed out that she joined the clinical trial “as a modest contribution to confronting Covid-19” and, even more so, because it is one of the vaccines that scientists and the country’s health system Caribbean “put at our disposal against this disease”.
Cuban vaccine opens new paths of collaboration with Italy (Photos+video+audio)
Similarly, for the political scientist Mattia Baldini, the main reason for his presence in the investigation was, on the one hand, political, because he considers the Cuban concept of universal and free health, detached from private financial interests, as “a very good example of How could a better world be?
Baldini’s second reason was “more personal, health, because Sovereign Plus had already had very good results in Cuba and, as I said, I totally trust Cuban health.”
When that opportunity arose “I said to myself, why not, in addition to supporting a political idea with which I totally agree”, also “I am going to get a vaccine that will protect me even more than the ones I have already gotten” , he remembered.
According to Baldini, it was a very nice experience and, above all, he remembers the care provided by the doctors from the Finlay Institute and La Pradera, “who woke us up very early every morning and asked us how we were, if we had a problem with the vaccine.”
Appreciation in Italy for Cuban vaccines against Covid-19 (+Photos +Video +Audio)
That level of detail, he said, has a lot to do with the idea that one may have of Cuban health because, to make a comparison, here in Europe you get the vaccine and you don’t know who made it, who invented it.
However, in Cuba, we were able to speak with the people who actually manufactured the vaccine, who developed the Soberana project, and all of this gives you an idea of how close you are to the scientific community, so to speak, much more than you he is used to it here in Europe, he said.
mar/junior high school
–
